PF-07284892

· Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PF-07284892, covering 2024-10-22 to 2024-10-22. Get the full timeline:

Most recent: Clinical Trial Update: PF-07284892 in Participants With Advanced Solid Tumors [Phase 1]